mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-07 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.001 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |